Literature DB >> 21972913

Safety and performance of TCI pumps in a magnetic resonance imaging environment.

R M Adapa1, R G Axell, J S Mangat, T A Carpenter, A R Absalom.   

Abstract

Target controlled infusion (TCI) devices can be associated with significant safety concerns when used during magnetic resonance imaging (MRI). We tested the safety and compatibility of newer TCI systems in a 3-Tesla MRI environment. Two Asena PK and two Agilia TCI pumps were used to administer TCI propofol (at target blood concentrations of 0.5 and 6.0 μg.ml⁻¹) using the Marsh model under magnetic fields of up to 50 G with a T2-weighted sequence. We assessed the devices for projectile risk, accuracy of drug delivery, alarm function and effects on MR image quality. Both devices did not demonstrate any significant deflection at the tested field strengths, and performed within acceptable limits (cumulative error in total delivered volume < 3%; maximum 10-min interval error < 10%). The Asena pump caused minor artefacts on MR images. The TCI pumps tested perform well and safely implement pharmacokinetic software in a high magnetic field. Anaesthesia
© 2011 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972913     DOI: 10.1111/j.1365-2044.2011.06917.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Accuracy assessment of a PION TCI pump based on international standards.

Authors:  Il Doh; Seok Hwan Lee; Yong-Hun Lee; Bokyoung Jeon; Byung-Moon Choi; Gyu-Jeong Noh
Journal:  Anesth Pain Med (Seoul)       Date:  2019-10-31

2.  Comparison of NREM sleep and intravenous sedation through local information processing and whole brain network to explore the mechanism of general anesthesia.

Authors:  Yun Li; Shengpei Wang; Chuxiong Pan; Fushan Xue; Junfang Xian; Yaqi Huang; Xiaoyi Wang; Tianzuo Li; Huiguang He
Journal:  PLoS One       Date:  2018-02-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.